Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Phys Biol. 2019 Jun 19;16(4):041005. doi: 10.1088/1478-3975/ab1a09

Figure 12.

Figure 12.

Correspondence of research strategies to the process of tumour evolution: Tumour heterogeneity is driven by clonal populations traversing evolutionary trajectories, the interactions between them, and the diversification that results. The milieu of molecular mechanisms that can be observed at the time of biopsy potentially confers finite drug sensitivity phenotypes.